PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,000 | -100.0% | 255 | -100.0% | 0.00% | -100.0% |
| Q4 2015 | $3,141,000 | -39.5% | 887,214 | -14.0% | 0.53% | -32.1% |
| Q3 2015 | $5,189,000 | -22.2% | 1,031,540 | -0.6% | 0.78% | -18.8% |
| Q2 2015 | $6,672,000 | -15.3% | 1,037,600 | -7.3% | 0.97% | -5.0% |
| Q1 2015 | $7,878,000 | -7.8% | 1,119,794 | +1.1% | 1.02% | -11.0% |
| Q4 2014 | $8,540,000 | -11.9% | 1,107,698 | -14.7% | 1.14% | -10.8% |
| Q3 2014 | $9,699,000 | – | 1,298,459 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |